泰格医药-中国创新药融资：2025 年进入收获期

Tigermed (3347.HK) Innovative drugs funding in China concluded a harvesting 2025 CITI'S TAKE Flash | 04 Jan 2026 18:00:07 ET │ 11 pages According to PharmaCube, the total financing size of innovative drugs (in both primary and secondary markets) in China soared 342% yoy to Rmb18.0bn in Dec 2025, reaching a new high in the past 3 years. China's innovative drugs primary market financing also grew strongly by 140% yoy to US$1.1bn in Dec 2025. For 2025, total financing/primary market financing size rose 38%/25% ...